1. Chen, Sisi, Geng, Xinwei, Syeda, Madiha Zahra, Zhang, Chao, Ying, Songmin. 2021. Human MUS81: A Fence-Sitter in Cancer. In Frontiers in cell and developmental biology, 9, 657305. doi:10.3389/fcell.2021.657305. https://pubmed.ncbi.nlm.nih.gov/33791310/
2. Wang, Mingchao, Ran, Xiaojuan, Leung, Wendy, Lawrence, Michael S, Zou, Lee. 2023. ATR inhibition induces synthetic lethality in mismatch repair-deficient cells and augments immunotherapy. In Genes & development, 37, 929-943. doi:10.1101/gad.351084.123. https://pubmed.ncbi.nlm.nih.gov/37932012/
3. Li, Chengguo, Shen, Qian, Zhang, Peng, Yin, Yuping, Tao, Kaixiong. 2021. Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells. In Journal of experimental & clinical cancer research : CR, 40, 315. doi:10.1186/s13046-021-02120-4. https://pubmed.ncbi.nlm.nih.gov/34625086/
4. Gong, Lifeng, Tang, Yu, Jiang, Li, Tang, Wei, Luo, Shengjun. 2022. Expression of MUS81 Mediates the Sensitivity of Castration-Resistant Prostate Cancer to Olaparib. In Journal of immunology research, 2022, 4065580. doi:10.1155/2022/4065580. https://pubmed.ncbi.nlm.nih.gov/35910852/
5. Wu, Fan, Su, Shu-Chao, Tan, Guo-Qian, Yu, Ji-Shang, Wang, Bai-Lin. 2017. Mus81 knockdown sensitizes colon cancer cells to chemotherapeutic drugs by activating CHK1 pathway. In Clinics and research in hepatology and gastroenterology, 41, 592-601. doi:10.1016/j.clinre.2017.01.011. https://pubmed.ncbi.nlm.nih.gov/28291626/
6. Coelho, Ricardo, Tozzi, Alessandra, Disler, Muriel, Jacob, Francis, Heinzelmann-Schwarz, Viola. 2022. Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer. In Cell death & disease, 13, 909. doi:10.1038/s41419-022-05347-x. https://pubmed.ncbi.nlm.nih.gov/36307400/
7. Zhang, Yan, Shi, Duo, Zhang, Xing, Liu, Wen, Luo, Bing. . Downregulation of MUS81 expression inhibits cell migration and maintains EBV latent infection through miR-BART9-5p in EBV-associated gastric cancer. In Journal of medical virology, 95, e28725. doi:10.1002/jmv.28725. https://pubmed.ncbi.nlm.nih.gov/37185865/
智鼠故事 
